Endocrinology

Triple negative

Questions discussed in this category

Would you consider hormone replacement therapy in young women with germline BRCA1 mutation and history of triple negative breast cancer who underwent bilateral mastectomy and prophylactic bilateral salpingo-oophorectomy?

This situation can feel uncomfortable. Would this feel safer if the patient is s/p mastectomy and had TNBC?

2 Answers available

Papers discussed in this category

Mol Cell Endocrinol, 2021 Jan 26

Hormone replacement therapy after breast cancer: Yes, No or maybe?

Lancet (London, England), 2004-02-07

HABITS (hormonal replacement therapy after breast cancer--is it safe?), a randomised comparison: trial stopped.

European journal of cancer (Oxford, England : 1990), 2012 Aug 11

Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial.

Related Topics in Endocrinology